BlackRock’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$67.2M Buy
5,924,567
+62,131
+1% +$705K ﹤0.01% 2252
2025
Q1
$39M Sell
5,862,436
-25,075
-0.4% -$167K ﹤0.01% 2486
2024
Q4
$64.9M Buy
5,887,511
+317,361
+6% +$3.5M ﹤0.01% 2277
2024
Q3
$68.5M Buy
5,570,150
+160,981
+3% +$1.98M ﹤0.01% 2264
2024
Q2
$73.1M Buy
5,409,169
+1,550,706
+40% +$21M ﹤0.01% 2192
2024
Q1
$52.1M Buy
3,858,463
+1,798,231
+87% +$24.3M ﹤0.01% 2370
2023
Q4
$10.8M Sell
2,060,232
-146,278
-7% -$769K ﹤0.01% 3287
2023
Q3
$8.69M Sell
2,206,510
-87,160
-4% -$343K ﹤0.01% 3366
2023
Q2
$24.4M Buy
2,293,670
+448,175
+24% +$4.76M ﹤0.01% 2852
2023
Q1
$15.4M Buy
1,845,495
+14,848
+0.8% +$124K ﹤0.01% 3036
2022
Q4
$16.9M Buy
1,830,647
+123,444
+7% +$1.14M ﹤0.01% 3064
2022
Q3
$21.9M Buy
1,707,203
+4,914
+0.3% +$63.1K ﹤0.01% 2936
2022
Q2
$22.5M Buy
1,702,289
+279,937
+20% +$3.7M ﹤0.01% 2966
2022
Q1
$29.9M Sell
1,422,352
-59,913
-4% -$1.26M ﹤0.01% 2853
2021
Q4
$35.6M Buy
1,482,265
+69,147
+5% +$1.66M ﹤0.01% 2859
2021
Q3
$35.9M Sell
1,413,118
-102,321
-7% -$2.6M ﹤0.01% 2847
2021
Q2
$51M Sell
1,515,439
-144,673
-9% -$4.87M ﹤0.01% 2655
2021
Q1
$64.5M Buy
1,660,112
+52
+0% +$2.02K ﹤0.01% 2428
2020
Q4
$103M Buy
1,660,060
+423,844
+34% +$26.2M ﹤0.01% 2036
2020
Q3
$41.4M Buy
1,236,216
+22,086
+2% +$740K ﹤0.01% 2355
2020
Q2
$28.9M Sell
1,214,130
-156,656
-11% -$3.73M ﹤0.01% 2568
2020
Q1
$31.4M Buy
1,370,786
+451,363
+49% +$10.3M ﹤0.01% 2323
2019
Q4
$26M Buy
919,423
+300,663
+49% +$8.51M ﹤0.01% 2702
2019
Q3
$13.3M Buy
618,760
+573,109
+1,255% +$12.3M ﹤0.01% 3021
2019
Q2
$1.33M Buy
+45,651
New +$1.33M ﹤0.01% 3866